Journal of Chemotherapy

Papers
(The median citation count of Journal of Chemotherapy is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Managing adult patients with infectious diseases in emergency departments: international ID-IRI study24
Comparison of lorlatinib, alectinib and brigatinib in ALK inhibitor–naive/untreated ALK-positive advanced non-small-cell lung cancer: a systematic review and network meta-analysis19
Activity of ceftolozane-tazobactam, ceftazidime-avibactam, meropenem-vaborbactam, cefiderocol and comparators against Gram-negative organisms causing bloodstream infections in Northern Italy (2019–20215
Infective endocarditis by Enterobacter cloacae: a systematic review and meta-analysis14
Luteolin suppresses lung cancer progression through targeting the circ_0000190/miR-130a-3p/notch-1 signaling pathway14
CircRNA_001895 promotes sunitinib resistance of renal cell carcinoma through regulation of apoptosis and DNA damage repair12
Evaluation of efficacy and safety of fosfomycin versus nitrofurantoin for the treatment of uncomplicated lower urinary tract infection (UTI) in women – A systematic review and meta-analysis12
Performance of capecitabine in novel combination therapies in colorectal cancer11
Anti-biofilm activity of dalbavancin against methicillin-resistant Staphylococcus aureus (MRSA) isolated from human bone infection11
Prognostic factors and effect on survival of immune-related adverse events in patients with non-small-cell lung cancer treated with immune checkpoint blockage11
Therapeutic options for COVID-19: a quick review10
Urinary tract infection in a human male patient with Staphylococcus pseudintermedius transmission from the family dog10
Metformin induces myeloma cells necrosis and apoptosis and it is considered for therapeutic use10
Circ_0007841 knockdown confers cisplatin sensitivity to ovarian cancer cells by down-regulation of NFIB expression in a miR-532-5p-dependent manner10
Investigation of anticancer activities of STA-9090 (ganetespib) as a second generation HSP90 inhibitor in Saos-2 osteosarcoma cells10
MiR-144-3p inhibits the proliferation, migration and invasion of lung adenocargen cancer cells by targeting COL11A110
miR-302a-3p suppresses melanoma cell progression via targeting METTL310
A plethora of carbapenem resistance inAcinetobacter baumannii: no end to a long insidious genetic journey10
Early 3-day course of remdesivir in vaccinated outpatients with SARS-CoV-2 infection. A success story9
LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis9
Infective endocarditis byKlebsiellaspecies: a systematic review9
Calcium-oxidative stress signaling axis and casein kinase 1α mediate eryptosis and hemolysis elicited by novel p53 agonist inauhzin9
Trabectedin-irinotecan, a potentially promising combination in relapsed desmoplastic small round cell tumor: report of two cases9
miR-4486 enhances cisplatin sensitivity of gastric cancer cells by restraining the JAK3/STAT3 signalling pathway9
FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer9
Knockdown of METTL5 inhibits the Myc pathway to downregulate PD-L1 expression and inhibits immune escape of hepatocellular carcinoma cells8
Voriconazole pharmacokinetics in a critically ill patient during extracorporeal membrane oxygenation8
C1q-like 1 is frequently up-regulated in lung adenocarcinoma and contributes to the proliferation and invasion of tumor cells8
Prognostic significance of sarcopenia and decreased relative dose intensity during the initial two cycles of first-line sunitinib for metastatic renal cell carcinoma8
In-vitro activity of fosfomycin against Escherichia coli and Klebsiella pneumoniae bloodstream isolates and frequency of OXA-48, NDM, KPC, VIM, IMP types of carbapenemases 8
Current treatments for inoperable mesothelioma: indirect comparisons based on individual patient data reconstructed retrospectively from 4 trials8
Application of tumoroids derived from advanced colorectal cancer patients to predict individual response to chemotherapy8
Relationship between renal dysfunction and electrolyte abnormalities in hematopoietic stem cell transplant patients treated with foscarnet8
Natural substances to potentiate canonical glioblastoma chemotherapy7
Novel daidzein molecules exhibited anti-prostate cancer activity through nuclear receptor ERβ modulation, in vitro and in vivo studies7
Initial trough concentration may be beneficial in preventing linezolid-induced thrombocytopenia7
Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center’s experience7
Infective endocarditis by Serratia species: a systematic review7
Pediatric impetigo: an expert panel opinion about its main controversies6
Efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant Klebsiella pneumoniae6
LncRNA-IQCH-AS1 sensitizes thyroid cancer cells to doxorubicin via modulating the miR-196a-5p/PPP2R1B signalling pathway6
Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients6
Epidemiology, aetiology and treatment of skin and soft tissue infections: final report of a prospective multicentre national registry6
Lambert-Eaton myasthenic syndrome (LEMS) in a patient with lung cancer under treatment with pembrolizumab: a case study6
Mechanisms underlying dose-limiting toxicities of conventional chemotherapeutic agents6
Effect of remdesivir on mortality rate and clinical status of COVID-19 patients: a systematic review with meta-analysis6
Proinflammatory circulating markers: new players for evaluating asymptomatic acute cardiovascular toxicity in breast cancer treatment6
Circ_SETD3 regulates gefitinib sensitivity and tumor progression by miR-873-5p-dependent regulation of APPBP2 in non-small cell lung cancer6
Infective endocarditis in patients with liver cirrhosis: a systematic review6
Activity of cefiderocol and synergy of novel β-lactam-β-lactamase inhibitor-based combinations against metallo-β-lactamase-producing gram-negative bacilli: insights from a two-year study (2019–2020)6
Capecitabine-associated enterocolitis: Narrative literature review of a rare adverse event and a case presentation6
Sorafenib for hepatocellular carcinoma: potential molecular targets and resistance mechanisms5
Risk of fatigue with PARP inhibitors in cancer patients: a systematic review and meta-analysis of 29 phase II/III randomized controlled trials5
Knockdown of microRNA-203 reduces cisplatin chemo-sensitivity to osteosarcoma cell lines MG63 and U2OS in vitro by targeting RUNX25
Anlotinib as a post-third-line therapy for the treatment of advanced nonsmall cell lung cancer5
Comparative incidence of acute kidney injury in patients on vancomycin therapy in combination with cefepime, piperacillin-tazobactam or meropenem5
The effect of PARP inhibitors in homologous recombination proficient ovarian cancer: meta-analysis5
The point prevalence and inappropriateness of antibiotic use at hospitals in Turkey: a systematic review and meta-analysis5
Dalbavancin treatment for spondylodiscitis: multi-center clinical experience and literature review5
Looking beyond ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae: in vitro activity of the novel meropenem-vaborbactam in combination with the old fosfomycin5
Effect of HDAC9 inhibition on epithelial-mesenchymal transition in CD133+ prostate cancer cell lines5
Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients5
Real life experience with ceftolozane/tazobactam therapy for Pseudomonas aeruginosa bacteremia4
Outcomes of diagnosed COVID-19 cancer patients: concerning results of a systematic review4
Optimization of dosing regimens of vancomycin, teicoplanin, linezolid and daptomycin against methicillin-resistant Staphylococcus aureus in neutropenic patients with cancer by Monte Carlo simul4
Pegylated liposomal doxorubicin as first line treatment in aids-related Kaposi’s sarcoma: a real-life study4
Vancomycin pharmacokinetics in patients treated with intermittent haemodialysis based on therapeutic drug monitoring4
Carbapenem-resistant Klebsiella pneumoniae outbreak in a COVID-19 intensive care unit; a case-control study4
Overcoming cisplatin resistance of human lung cancer by sinomenine through targeting the miR-200a-3p-GLS axis4
Bictegravir/emtricitabine/tenofovir alafenamide combination in the management of kidney transplant patients with HIV receiving immunosuppressants4
Risk of hypertension with anti-VEGF monoclonal antibodies in cancer patients: a systematic review and meta-analysis of 105 phase II/III randomized controlled trials4
Endocarditis in kidney transplant recipients: a systematic review4
Linezolid-related adverse effects in the treatment of rifampicin resistant tuberculosis: a retrospective study4
Relationship between pathological response and molecular subtypes in locally advanced breast cancer patients receiving neoadjuvant chemotherapy4
Amoxicillin-associated Stevens-Johnson syndrome or toxic epidermal necrolysis: systematic review4
Pharmacodynamics of D-mannose in the prevention of recurrent urinary infections4
Recovery of borderline oxacillin-resistant Staphylococcus pseudintermedius (BORSP) from bone and soft tissue of a rheumatoid arthritis patient with severe osteoporosis: transmission from the fa4
Fosfomycin therapeutic drug monitoring in real-life: development and validation of a LC-MS/MS method on plasma samples4
Overexpression of long non-coding RNA urothelial carcinoma associated 1 causes paclitaxel (Taxol) resistance in colorectal cancer cells by promoting glycolysis4
MAP7 promotes proliferation and migration of breast cancer cells and reduces the sensitivity of breast cancer cells to paclitaxel4
Disseminated fusariosis in immunocompromised children: a case series and review of literature4
The tumor microenvironment: shaping cancer progression and treatment response4
Frizzled-3 suppression overcomes multidrug chemoresistance by Wnt/β-catenin signaling pathway inhibition in hepatocellular carcinoma cells4
Circ_0048856 competes with ABCC1 for miR-193a-5p/miR-98-5p binding sites to promote the cisplatin resistance and tumorigenesis in lung cancer4
Dalbavancin as chronic antibiotic suppression therapy for left ventricular assist device driveline infection due to methicillin-resistant Staphylococcus aureus: a case report4
Oral fosfomycin for treating lower urinary tract infections due to multidrug-resistant Escherichia coli in female adolescents3
Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey3
Impact of ward pharmacist-led antimicrobial stewardship in intensive care units3
Combination therapy of vancomycin and piperacillin/tazobactam in adult febrile neutropenia patients with haematopoietic malignancies increases the risk of acute kidney injury regardless of vancomycin 3
Depletion of circPDSS1 inhibits ITGA11 production to confer cisplatin sensitivity through miR-515-5p in gastric cancer3
Triptolide inhibits T-cell acute lymphoblastic leukaemia by affecting aberrant epigenetic events in the Wnt signalling pathway3
In vitro and in vivo comparison of eravacycline- and tigecycline-based combination therapies for tigecycline-resistant Acinetobacter baumannii3
Evaluation of the post-antibiotic effectin vivofor the combination of a β-lactam antibiotic and a β-lactamase inhibitor: ceftazidime-avibactam in neutropenic mouse thigh and lung infections3
Systematic review and meta-analysis of the predictive power of MTHFR polymorphisms for pemetrexed drug efficacy and toxicity in non-small cell lung cancer patients3
DPYDandTYMSpolymorphisms as predictors of 5 fluorouracil toxicity in colorectal cancer patients3
Drugs and liver injury: a not to be overlooked binomial in COVID-193
MTHFR polymorphism as a predictive biomarker for gastrointestinal and hematological toxicity in North Indian adenocarcinoma patients3
Recent advances in caspase-3, breast cancer, and traditional Chinese medicine: a review3
High dose methotrexate in adult Egyptian patients with hematological malignancies: impact of ABCB1 3435C > T rs1045642 and MTHFR 677C > T rs1801133 polymorphisms on toxicities and delayed elimin3
In vitro killing of multidrug/extensively drug-resistant Pseudomonas aeruginosa by fosfomycin alone or in combination with antipseudomonal antibiotics3
Conceptual framework of antibiotic stewardship programs in reducing ESBL-producing Enterobacteriaceae: a systematic review and meta-analysis3
Identification of T cell-related biomarkers for breast cancer based on weighted gene co-expression network analysis3
Cost-effectiveness analysis of pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer3
Analysis of the clinical characteristics of tigecycline-induced hypofibrinogenemia3
Oral step-down therapy in patients with uncomplicated Staphylococcus aureus primary bacteremia and catheter-related bloodstream infections3
Long-term physico-chemical stability of 5-fluorouracile at standardised rounded doses (SRD) in MyFuser® portable infusion pump3
ESBL-producing Escherichia coli and Klebsiella pneumoniae from health-care institutions in Mexico3
Correlation of gemcitabine sensitization by Chk1 inhibition with p53 status3
Mechanisms and applications of ferroptosis-associated regulators in cancer therapy and drug resistance2
PD-1 inhibitors plus chemotherapy as first-line therapy for stage IV ESCC2
Current status of systemic therapy in head and neck cancer2
Ceftobiprole and daptomycin concentrations in valve tissue in a patient with mitralic native valve endocarditis2
Osimertinib and chemotherapy combination to treat brain metastasis flare and osimertinib resistance by EGFR C797S2
Sorafenib tosylate-loaded nanosuspension: preparation, optimization, and in vitro cytotoxicity study against human HepG2 carcinoma cells2
Efficacy of the VIT (vincristine, irinotecan and temozolomide) regimen in adults with metastatic Ewing sarcoma2
Hydrolytic activity of KPC-producing Klebsiella pneumoniae clinical isolates2
Comparisons of effects of SOX and mFOLFOX6 chemotherapy regimens on patients with locally advanced gastric cancer2
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) therapy increases carotid intima-media thickness and plaque score with von Willebrand factor activity elevation in pati2
Combined impact of hypoalbuminemia and pharmacogenomic variants on voriconazole trough concentration: data from a real-life clinical setting in the Chinese population2
In vitro activity of newer β-lactam/β-lactamase inhibitor combinations, cefiderocol, plazomicin and comparators against carbapenemase-producing Klebsiella pneumoniae<2
Dysgeusia in patients with advanced urothelial carcinoma receiving enfortumab vedotin, platinum-based chemotherapy, or immune check point inhibitors: time-course assessment using chemotherapy-induced 2
Efflux pump effects on Mycobacterium tuberculosis drug resistance2
Long-term positive effect of an educational antimicrobial stewardship program implemented in an Internal Medicine Department: a prospective analysis and a point prevalence survey on long-term effect2
Mpox vaccination and treatment: a systematic review2
Comparison of first line chemotherapy regimens for advanced soft tissue sarcoma: a network meta-analysis2
Daptomycin for the successful treatment of postoperative methicillin-resistant Staphylococcus aureus empyema: a case report2
Amikacin-induced acute kidney injury in mechanically ventilated critically ill patients with sepsis2
A novel polymerase β inhibitor from phage displayed peptide library augments the anti-tumour effects of temozolomide on colorectal cancer2
Dual targeting Bcl-2 and Bcl-xL augments osteosarcoma response to doxorubicin2
Emergency department care of ABSSSI with dalbavancin infusion, direct discharge, and outpatient telemedicine follow up: a study protocol2
Impact of antibiotic susceptibility reporting on broad spectrum antibiotic use in serratia and morganella bacteremia2
Transmembrane protein ADAM29 facilitates cell proliferation, invasion and migration in clear cell renal cell carcinoma2
LncRNA POU6F2-AS2 contributes to malignant phenotypes and paclitaxel resistance by promoting SKP2 expression in stomach adenocarcinoma2
Comparative in vitro effectiveness of ceftolozane/tazobactam against pediatric gram-negative drug-resistant isolates2
Inhibiting effect of p-Coumaric acid on U87MG human glioblastoma cell growth2
BEZ235 reduction of cisplatin resistance on wild-type EGFR non-small cell lung cancer cells1
Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology 1
Antimicrobial dosing recommendations during continuous renal replacement therapy: different databases, different doses1
Intraventricular treatment of paediatric meningitis due to extensively drug-resistant Gram-negative bacteria: two case reports and review of the literature1
YAP/TAZ axis was involved in the effects of metformin on breast cancer1
Assessing the prevalence and severity of cisplatin-induced nephrotoxicity in a minority- low socioeconomic population in the Bronx, New York1
Comparison of venetoclax and ivosidenib/enasidenib for unfit newly diagnosed patients with acute myeloid leukemia and IDH1/2 mutation: a network meta-analysis1
Global status of phenotypic pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates: an updated systematic review and meta-analysis1
Establishing and characterizing a novel doxorubicin-resistant acute myeloid leukaemia cell line1
Quality control and consistency evaluation of ceftriaxone sodium for injection1
Time to reconsider moxifloxacin anti-anaerobic activity?1
Impact of clinical pharmacist’s interventions on clinical outcomes in appropriate use of colistin: a prospective pre-post intervention study1
Impact of a hospital sepsis management protocol on the selection of empirical antibiotics in infectious disease consultations1
The effectiveness of cetuximab and panitumumab when combined with FOLFIRI in second-line treatment of KRAS wild type metastatic colorectal cancers. Single centre experience1
Antibiotic resistance in Campylobacter jejuni and Campylobacter coli: significant contribution of an RND type efflux pump in erythromycin 1
MiR-302a-3p reduces cisplatin resistance of esophageal squamous cell carcinoma cells by targeting EphA21
Resveratrol suppresses NSCLC cell growth, invasion and migration by mediating Wnt/β-catenin pathway via downregulating SIX4 and SPHK21
Improving therapeutic resistance: beginning with targeting the tumor microenvironment1
Tumor mutational burden in non-immunotherapy patients with heavily pretreated metastatic breast cancer: long-term outcomes from a single institution1
Benefit from Almonertinib after Osimertinib treat EGFR 19 exon deletion NSCLC induced Severe rash: a case report1
Ventriculitis and meningitis: by methicillin-resistant S. epidermidis: comparison of serum and CSF vancomycin concentrations and possible effect on MIC1
Importance of daptomycin dosage on the clinical outcome in liver transplant recipients with vancomycin-resistant enterococci infection1
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis1
RANK pathway in cancer: underlying resistance and therapeutic approaches1
Evaluation of synergistic activity of plazomicin-based combinations against KPC-producing Klebsiella pneumoniae with complex multidrug resistance phenotypes1
The BioWipe: a non-invasive method to detect intestinal carriage of multi-drug resistant GRAM-negative bacteria1
The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing1
BR (bendamustine plus rituximab) versus R-CHOP for patients with indolent B-cell lymphomas: a systematic review and Meta-analysis1
Carbapenem-resistant Gram-negative pathogens associated with septic shock: a review of 120 cases1
In vitro susceptibility of carbapenem-resistant Enterobacterales to eravacycline – the first report from Croatia1
Camrelizumab-induced anaphylactic reaction: a case report and literature review1
The rising problem of hospital antimicrobial resistance and the challenges of antibiotic prescription in Brazil1
Irreversible Cabozantinib-induced left ventricular systolic dysfunction, a potentially novel observation1
Aminoglycosides’ dosing and monitoring practices in critically ill patients in Quebec hospitals1
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge1
Optimization of the vancomycin administration regimen by clinical pharmacists based on a population pharmacokinetics model: a prospective interventional study1
Astaxanthin induces autophagy and apoptosis in murine melanoma B16F10-Nex2 cells and exhibits antitumor activity in vivo1
Factors associated with immune-related thyroid dysfunction induced by PD-1/PD-L1 inhibitors in cancer patients: an observational study1
Successful treatment of postsurgical meningitis caused by Bacillus cereus : a case report and literature review1
LncRNA DLEU2 contributes to Taxol resistance of gastric cancer cells through regulating the miR-30c-5p-LDHA axis1
Meta-analysis of echinocandins combined with trimethoprim-sulfamethoxazole for treatment of Pneumocystis pneumonia1
A comparative study of ceftazidime/avibactam-based and fosfomycin plus meropenem-based regimens for managing infections caused by carbapenem-resistant Klebsiella pneumoniae 1
Vancomycin-resistant enterococcus bloodstream infection successfully managed with oritavancin and fosfomycin as sequential treatment1
VEGF single nucleotide polymorphisms predict improved outcome in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy1
Anti-programmed death ligand 1 immunotherapy in patients with limited-stage small cell lung cancer: a real-world exploratory study1
Retrospective analysis of risk factors for levofloxacin-induced liver injury1
Potential role of genetic polymorphisms in neoadjuvant chemotherapy response in breast cancer1
Assessment of micafungin dosage regimens against Candida spp. in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic/pharmacodynamic1
TPD7 inhibits the non-small cell lung cancer HCC827 cell growth by regulating EGFR signalling pathway1
Infective endocarditis by Actinomyces species: a systematic review1
Risk-adjusted analysis of survival variability among hospitals treating biliary malignancy1
Combination of mTOR inhibitor PP242 and AMPK activator metformin exerts enhanced inhibitory effects on colorectal carcinoma cells in vitro by blocking multiple kinase pathways1
Is ceftriaxone a suitable option for the empirical treatment of postoperative pleural empyema?1
Effectiveness and safety of a disposable elastomeric continuous infusion pump for outpatient parenteral antimicrobial therapy (OPAT) in a UK setting1
Co-occurrence of triple carbapenemase genes, bla VIM-2 , bla NDM-1 , and bla<1
Advances in MUC1 resistance to chemotherapy in pancreatic cancer1
Prolonged clinical response with regorafenib administered as second-line therapy in an elderly patient suffering from peritoneal carcinomatosis of colon cancer1
Hypomethylating agents combined with low-dose chemotherapy for elderly patients with acute myeloid leukaemia unfit for intensive chemotherapy: a real-world clinical experience1
Class 1, 2 and 3 integrons in clinical Pseudomonas aeruginosa isolated from Tanta University Hospitals, Egypt1
microRNA-143 interferes the EGFR-stimulated glucose metabolism to re-sensitize 5-FU resistant colon cancer cells via targeting hexokinase 21
Amikacin treatment in urinary tract infection patients: evaluating the risk of acute kidney injury – a retrospective cohort study1
Are there differences between ceftolozane/tazobactam and ceftazidime/avibactam in treating patients with complicated abdominal infections? Evidence from clinical trials1
0.044509887695312